Inhibition of HIV-1 RNase H activity by nucleotide dimers and monomers

Antiviral Chemistry and Chemotherapy

Volumn 7, Issue 1, 1996, Pages 37-45

  Allen, S J W ^a   Krawczyk, S H ^a   McGee, L R ^a   Bischofberger, N ^a   Mulato, A S ^a   Cherrington, J M ^a  

^a GILEAD SCIENCES   (United States)

Author keywords

HIV; Inhibition; Nucleotides; RNase H

Indexed keywords

ANTIVIRUS AGENT; DIMER; MONOMER; NUCLEOTIDE DERIVATIVE; RIBONUCLEASE; RNA DIRECTED DNA POLYMERASE; VIRUS ENZYME;

ANTIVIRAL ACTIVITY; ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME KINETICS; FELINE IMMUNODEFICIENCY VIRUS; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; RETROVIRUS; STRUCTURE ACTIVITY RELATION;

EID: 0030061628     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632029600700107     Document Type: Article

References (34)

1. Andreola, M.L., Tharaud, D., Litvak, S., and Tarrago-Litvak, L. (1993) The ribonuclease H activity of HIV-1 reverse transcriptase: further biochemical characterization and search of inhibitors. Biochimie 75: 127-134.
2. Buiser, R.G., DeStefano, J.J., Mallaber, L.M., Fay, P.J., and Bambara, R.A. (1991) Requirements for the catalysis of strand transfer synthesis by retroviral DNA polymerases. J Biol Chem 266: 13103-13109.
3. Champoux, J.J., Gilboa, E., and Baltimore, D. (1984) Mechanism of RNA primer removal by the RNase H activity of avian myeloblastosis virus reverse transcriptase. J Virol 49: 686-691.
4. Cherrington J.M., Allen, S.J.W., McKee, B.H., and Chen, M.S. (1994) Kinetic analysis of the interaction between the diphosphate of (S)-1-(3-Hydroxy-2- Phosphonylmethoxypropyl)cytosine, ddCTP, AZTTP, and FIAUTP with human DNA polymerases β and γ. Biochem Pharmacol 48: 1986-1988.
5. Cleland, W.W. (1979) Statistical analysis of enzyme kinetic data. Methods in Enzymology 63: 103-138.
6. Furman, P.A., Fyfe, J.A., St. Clair, M.H., Weinhold, R., Rideout, J.L., Freeman, G.A., Lehrman, S.H., Bolognesi, D.P., Broder, S., Mitsuya, H., and Barry, D.W. (1986) Phosphorylation of 3′-azido-3′-deoxythymidine and selective interaction of the 5′- triphosphate with human immunodeficiency virus reverse transcriptase. Proc Natl Acad Sci USA 83: 8333-8337.
7. Hizi, A., Tal, R., Shaharabany, M., and Loya, S. (1991) Catalytic properties of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2. J Biol Chem 266: 6230-6239.
8. Krug, M., and Berger, S.L. (1989) Ribonuclease H activities associated with viral reverse transcriptases are endonucleases. Proc Natl Acad Sci USA 86: 3539-3543.
9. Krug, M., and Serger, S.L. (1991) Reverse transcriptase from human immunodeficiency virus: a single template-primer binding site serves two physically separable catalytic functions. Biochem 30: 10614-10623.
10. Loya, S., Tal, R., Kashman, Y., and Hizi, V. (1990) Illimaquinone, a selective inhibitor of the RNase H activity of human immunodeficiency virus type 1 reverse transcriptase. Antimicrob Agents Chemother 43: 2009-2012.
11. Loya, S., and Hizi, A. (1993) The interaction of Illimaquinone, a selective inhibitor of RNase H activity, with reverse transcriptases of human immunodeficiency and murine leukemia viruses. J Biol Chem 268: 9323-9328.
12. Mitra, S.W., Chow, M., Champoux, J., and Baltimore, D. (1982) Synthesis of murine leukemia virus plus strong stop DNA initiates at a unique site. J Biol Chem 257: 5983-5986.
13. Mitsuya, H., and Broder, S. (1986) Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2′,3′- dideoxynucleosides. Proc Natl Acad Sci USA 83: 1991-1915.
14. Modak, M.J., and Marcus, S.L. (1977) Specific inhibition of DNA polymerase associated RNase H by DNA. J Virol 22: 243-246.
15. Moelling, K., Bolognesi, D.P., Bauer, H., Busen, W., Plassman, H.W., and Hausen, P. (1971) Association of viral reverse transcriptase with an enzyme degrading the RNA moiety of RNA-DNA hybrids. Nature New Biology 234: 240-243.
16. Moelling, K., Schultze, T., and Diringer, H. (1989) Inhibition of human immunodeficiency virus type 1 RNase H by sulfated polyanions. J Virol 63: 5489-5491.
17. North, T.W., Cronn, R.C., Remington, K.M., Tandberg, R.T., and Judd, R.C. (1990) Characterization of reverse transcriptase from feline immunodeficiency virus. J Biol Chem 265: 5121-5128.
18. North, T.W., Cronn, B.C., Remington, K.M., and R.T. Tandberg, (1990) Direct comparisons of inhibitor sensitivities of reverse transcriptases from feline and human immunodeficiency viruses. Antimicrob Agents Chemother 34: 1505-1507.
19. North, T.W., North, G.T., and Pedersen, N.C. (1989) Feline immunodeficiency virus, a model for reverse transcriptasetargeted chemotherapy for acquired immune deficiency syndrome. Antimicrob Agents Chemother 33: 914-919.
20. Trp primer molecule from viral DNA by ribonuclease H during reverse transcription. Cell 30: 797-805.
21. Ostertag, W., Roesler, G., Krieg, C.J., Kind, J., Cole, T., Crozier, T., Gaedicke, G., Steinheider,G., Kluge, N., and Dube, S. (1974) Induction of endogenous virus and of thymidine kinase by bromodeoxyuridine in cell cultures transformed by Friend virus. Proc Natl Acad Sci USA 71: 4980-4985.
22. Repaske, R., Hartley, J.W., Kavlick, M.F., O'Neill, R.R., and Austin, J.B. (1991) Inhibition of RNase H activity and viral replication by single mutations in the 3′ region of Moloney Leukemia Virus reverse transcriptase. J Virol 63: 1460-1464.
23. Resnick, R., Omer, C.A., and Faras, A.J. (1984) Involvement of retrovirus reverse transcriptase-associated RNase H in the initiation of strong stop (+) DNA synthesis and the generation of the long terminal repeat. J Virol 51: 813-821
24. Schatz, O., Mous, J., and LeGrice, S.F.J. (1990) HIV-1 RT-associated ribonuclease H displays both endonuclease and 3′ to 5′ exonuclease activity. EMBO J 9: 1171-1176.
25. Smith, J.K., Cywinski, A., and Taylor, J.M. (1984) Specificity of initiation of plus-strand DNA by Rous sarcoma virus. J Virol 49: 200-204.
26. Stames, M.C., and Cheng. Y. (1989) Human Immunodeficiency Virus Reverse Transcriptase-associated RNase H activity. J Biol Chem 264: 7073-7077.
27. Take, Y., Inouye, Y., and Nakamura, S. (1988) Comparative studies of the inhibitory properties of antibiotics on human immunodeficiency virus and avian myeloblastosis virus reverse transcriptases and cellular DNA polymerases. J Antibiot 62: 107-115.
28. Tan, C., Civil, R., Mian, A.M., So, A.G., and Downye, K.M. (1991) Inhibition of the RNase H activity of HIV reverse transcriptase by azidothymidylate. Biochem 30: 4831-4835.
29. Telesnitsky, A., Blain, S.W., and Goff, S.P. (1992) Defects in moloney murine leukemia virus replication caused by a reverse transcriptase mutation modeled on the structure of Escherichia coli RNase H. J Virol 66: 615-622.
30. Tisdale, M., Schulze, T., Larder, B.A., and Moelling, K. (1991) Mutations within the RNase H domain of human immunodeficiency virus type 1 reverse transcriptase abolish virus infectivity. J Gen Virol 72: 59-66.
31. Varmus, H., and Swanstrom, R. (1984) in RNA Tumor Viruses Weiss, R., Teich, N., Varmus, H., and Coffin, J. (eds.) 2nd edition, Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory Publications. pp 369-512.
32. Verma, I.M. (1975) Studies on reverse transcriptase of RNA tumor viruses. III. Properties of purified Moloney murine leukemia virus DNA polymerase and associated RNase H. Biochim Biopys Acta 473: 1-38.
33. Weislow, O.S., Kiser, D.L., Fine, D.L., Bader, J., Shoemaker, R.H., and Boyd, M.R. (1989) New soluble formazan assay for HIV-1 cytopathic effects: application to high-flux screening of synthetic and natural products for AIDS-antiviral activity. J Natl Cancer Inst 81: 577-586.
34. Zhan, X., Tan, C., Scott, W.A., Mian, A.M., Downey, K.M., and So, A.G. (1994) Catalytically distinct conformations of the ribonuclease H of HIV-1 reverse transcriptase by substrate cleavage patterns and inhibition by azidothymidylate and N-ethylmaleimide. Biochem 33: 1366-1372.